Important notice about stem cell research

As we seek to reduce the spread of the SARS-CoV-2 virus, laboratory-based research at Harvard has been put on hold, with the exception of research into COVID-19. We are working remotely, and maintaining only the most critical functions to safeguard materials that are essential to our mission of finding cures and better treatments for human disease. Visit the Harvard University coronavirus website for university-wide information, and the ISSCR coronavirus page for stem-cell community resources.


Our mission is to find cures for human diseases.


The Harvard community and the greater Boston area are home to the largest concentration of biomedical researchers in the world. This allows our network of over 1,000 scientists, from across Harvard and its eight affiliated hospitals, to advance stem cell biology and translational medicine in a way no other single entity can.


Through collaborative research, we seek to:

• Stimulate healing in patients by harnessing the potential of stem cells

• Create targeted treatments by combining new gene- and cell-based therapies with traditional medicines

• Accelerate drug discovery by developing novel stem cell-based tools.



HSCI Community Events

2020 Sep 24

4th Biennial International Ocular Regeneration Symposium | From Bench to Bedside

8:00am to 6:00pm



Ocular Regeneration Image

You're invited to join clinicians and basic scientists at the upcoming International Symposium on Ocular Regeneration in 2020. Lectures and panel discussions will focus on how to transform basic research into novel treatments for degenerative eye diseases of the anterior and posterior segments.


Read more about 4th Biennial International Ocular Regeneration Symposium | From Bench to Bedside
Read more